Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126352591 | 12635259 | 1 | I | 20150511 | 20160728 | 20160809 | 20160809 | EXP | CA-HQ SPECIALTY-CA-2016INT000742 | INTERCHEM | 46.00 | YR | F | Y | 0.00000 | 20160809 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126352591 | 12635259 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | STRENGTH: 1 MG (10 MG,1 IN 1 W) | 201749 | 10 | MG | TABLET | |||||||
| 126352591 | 12635259 | 2 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 3.5714 MG (25 MG,1 IN 1 W) | 201749 | 25 | MG | TABLET | |||||||
| 126352591 | 12635259 | 3 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 10 MG (5 MG,2 IN 1 D) | 0 | 5 | MG | ||||||||
| 126352591 | 12635259 | 4 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 1500 MG (1500 MG,1 IN 1 D) | 0 | 1500 | MG | ||||||||
| 126352591 | 12635259 | 5 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Oral | 800 MG (400 MG, 2 IN 1 D) | U | 0 | |||||||||
| 126352591 | 12635259 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | AFTER METHOTREXATE (SO TAKEN SATURDAYS) (1 DOSAGE FORM,1 IN 1 W) | U | 0 | TABLET | |||||||||
| 126352591 | 12635259 | 7 | C | NAPROSYN | NAPROXEN | 1 | Oral | 500 MG (500 MG,1 IN 1 D) | U | 0 | 500 | MG | |||||||
| 126352591 | 12635259 | 8 | C | TRAMADOL. | TRAMADOL | 1 | (2 DOSAGE FORM,6 H) | U | 0 | TABLET | |||||||||
| 126352591 | 12635259 | 9 | C | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | 400 MG (400 MG,1 IN 1 D) | U | 0 | 400 | MG | ||||||||
| 126352591 | 12635259 | 10 | C | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | 10 MG, 1 D | Y | 0 | 10 | MG | ||||||||
| 126352591 | 12635259 | 11 | C | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | 20 MG, 1 D | Y | 0 | 20 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126352591 | 12635259 | 1 | Rheumatoid arthritis |
| 126352591 | 12635259 | 3 | Rheumatoid arthritis |
| 126352591 | 12635259 | 4 | Rheumatoid arthritis |
| 126352591 | 12635259 | 5 | Rheumatoid arthritis |
| 126352591 | 12635259 | 6 | Rheumatoid arthritis |
| 126352591 | 12635259 | 7 | Rheumatoid arthritis |
| 126352591 | 12635259 | 8 | Pain |
| 126352591 | 12635259 | 9 | Product used for unknown indication |
| 126352591 | 12635259 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126352591 | 12635259 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126352591 | 12635259 | Dizziness | |
| 126352591 | 12635259 | Headache | |
| 126352591 | 12635259 | Malaise | |
| 126352591 | 12635259 | Nausea | |
| 126352591 | 12635259 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126352591 | 12635259 | 1 | 2011 | 0 | ||
| 126352591 | 12635259 | 3 | 20150509 | 0 | ||
| 126352591 | 12635259 | 9 | 201204 | 0 | ||
| 126352591 | 12635259 | 10 | 201207 | 0 | ||
| 126352591 | 12635259 | 11 | 20120716 | 2016 | 0 |